Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 100960-07-4 | MDL No. : | MFCD06659683 |
Formula : | C7H7N3 | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | PLWBENCHEUFMTN-UHFFFAOYSA-N |
M.W : | 133.15 | Pubchem ID : | 11715187 |
Synonyms : |
|
Num. heavy atoms : | 10 |
Num. arom. heavy atoms : | 9 |
Fraction Csp3 : | 0.0 |
Num. rotatable bonds : | 0 |
Num. H-bond acceptors : | 1.0 |
Num. H-bond donors : | 2.0 |
Molar Refractivity : | 40.5 |
TPSA : | 54.7 Ų |
GI absorption : | High |
BBB permeant : | Yes |
P-gp substrate : | No |
CYP1A2 inhibitor : | Yes |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -6.66 cm/s |
Log Po/w (iLOGP) : | 0.9 |
Log Po/w (XLOGP3) : | 0.63 |
Log Po/w (WLOGP) : | 1.15 |
Log Po/w (MLOGP) : | 0.37 |
Log Po/w (SILICOS-IT) : | 1.36 |
Consensus Log Po/w : | 0.88 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 1.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -1.73 |
Solubility : | 2.49 mg/ml ; 0.0187 mol/l |
Class : | Very soluble |
Log S (Ali) : | -1.35 |
Solubility : | 5.9 mg/ml ; 0.0443 mol/l |
Class : | Very soluble |
Log S (SILICOS-IT) : | -2.52 |
Solubility : | 0.404 mg/ml ; 0.00303 mol/l |
Class : | Soluble |
PAINS : | 0.0 alert |
Brenk : | 0.0 alert |
Leadlikeness : | 1.0 |
Synthetic accessibility : | 1.44 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H302-H319 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
100% | With palladium 10% on activated carbon; hydrogen In methanol at 20℃; Inert atmosphere | To a stirred solution of 5nitro7azaindoie (500 rng, 3.07 rnmol) in methanol (125 rnL) under nitrogen atmosphere was added 10percent Pd/C (326 mg, 0.306 rnmol). The reaction was placed under an atmosphere of hydrogen gas and stirred at 20 °C overnight. The suspension was filtered through a pad of Celite® 545, the resulting filter cake was washed with MeOH, and the combined organicphases concentrated in vaeuo to afford the title compound (408 mg, 100percent). MS (ES1): mass calcd. for C7HN3 133.1, rn/z found 133.9 [M+H]t. ‘H NMR (300 MHz, DMSO-d6) ö 11.04 (s, 1H), 7.70 (d, J= 2.4 Hz, iH, 7.27 —7.18 (m, 1ff), 7.08 (d, J= 2.3 Hz, IH), 6.22 —6.06 (m, 1H), 4.62 (s, 2H). |
95% | With hydrogen In ethyl acetate for 4 h; | To a solution of 5-nitro-1H-pyrrolo[2,3-b]pyridine (0.4 g, 2.45 mmol) in ethyl acetate (100 mL) 5percent Pd-C (0.3 g) was added and the mixture subdued to hydrogenation (30 psi) in a Parr apparatus. After 4 hours the catalyst was filtered off through celite, the cake was washed with ethyl acetate and then with a mixture of dichloromethane/methanol 4:1. 1H-pyrrolo[2,3-b]pyridin-5-amine (5-aminoazaindole) was obtained in 95percent yield (0.31 g, 2.33 mmol). 1H-NMR (DMSOd6), δ ppm: 4.62 (s, 2 H) 6.17 (dd, J=3.29, 1.95 Hz, 1 H) 7.10 (dd, J=2.50, 0.55 Hz, 1 H) 7.24 (t, J=2.87 Hz, 1 H) 7.72 (d, J=2.56 Hz, 1 H) 11.04 (s, 1 H). |
90% | With hydrogen In tetrahydrofuran; ethanol for 2 h; | Example 12 [Show Image]; (E)-3-(5-Phenylacetylamino-1H-pyrrolo[2,3-b]pyridin-3-yl)-acrylamide; Step 1; 4 gr. (25 mmole) of 5-nitroazaindole (registry number 101083-92-5) were dissolved in 500 ml of ethanol and 150 ml of tetrahydrofuran and hydrogenated with a Parr apparatus after addition of 2 gr of Pd/C 10percent in 2 hrs. After filtration through a plug of celite and recrystallization from toluene/dicloromethane 3 gr of pure 5-aminoazaindole (1) were obtained (90percent yield). 1H NMR (400 MHz, DMSO-D6) δ ppm 4.62 (s, 2 H) 6.17(dd, J=3.29,1.95 Hz, 1 H) 7.10 (dd, J=2.50,0.55 Hz, 1 H) 7.24 (t, J=2.87 Hz, 1 H) 7.72 (d, J=2.56 Hz, 1 H) 11.04 (s, 1 H ) |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
63% | With ammonia; copper(II) sulfate In waterin a sealed tube; Heating / reflux | [0250] 5-bromo-lH-pyrrolo[2,3-b]ρyridine (6.Og, 30.45mmol) in ammonium hydroxide (12OmL) was treated with copper sulphate pentahydrate (1.50g, 6.09mmol, 0.2 eq) and heated in a sealed tube overnight. The reaction was diluted with EtOAc and the insoluble black solid was filtered off. The filtrate was extracted (EtO Ac/Water) and the organic layer washed with saturated aqueous ammonium chloride, followed by water and brine. The organics were dried over magnesium sulphate, filtered and evaporated to dryness to give the product as a pale brown solid (2.57g, 63percent) |
[ 74420-00-1 ]
4-Amino-1H-pyrrolo[2,3-b]pyridine
Similarity: 0.89
[ 267876-25-5 ]
(1H-Pyrrolo[2,3-b]pyridin-5-yl)methanamine
Similarity: 0.89
[ 1134307-94-0 ]
1H-Pyrrolo[2,3-b]pyridin-4-amine hydrochloride
Similarity: 0.87
[ 869335-48-8 ]
1-Methyl-1H-pyrrolo[2,3-b]pyridin-4-amine
Similarity: 0.85
[ 145901-11-7 ]
1H-Pyrrolo[2,3-b]pyridin-6-amine
Similarity: 0.83
[ 824-24-8 ]
4-Methyl-1H-pyrrolo[2,3-b]pyridine
Similarity: 0.93
[ 824-52-2 ]
5-Methyl-1H-pyrrolo[2,3-b]pyridine
Similarity: 0.90
[ 74420-00-1 ]
4-Amino-1H-pyrrolo[2,3-b]pyridine
Similarity: 0.89
[ 23612-48-8 ]
2-Methyl-1H-pyrrolo[2,3-b]pyridine
Similarity: 0.89